Tag: Epilepsy
Neighborhood Socioeconomic Status Tied to Mortality for Neurologic Conditions
Increased odds of 30-day mortality ranges from 2.46 to 1.23 for nontraumatic coma and stroke
Fear of Public Places Common in Adults With Epilepsy
Furthermore, this fear is associated with poor quality of life
Racial/Ethnic Minorities Less Likely to Use Newer Antiseizure Meds
Odds of being on newer ASMs increased for those who saw a neurologist, were newly diagnosed with epilepsy
Modified Atkins Diet Plus Drug Therapy Beneficial in Drug-Resistant Epilepsy
Modified Atkins diet added to standard drug treatment more effective for reducing seizure frequency than standard drug therapy alone
Antiepileptic Drugs Tied to Incident Parkinson Disease
Magnitude of the association increased with the number of antiepileptic drugs prescribed
Seizures, Epilepsy Up in Six Months After COVID-19 Infection
Hazard ratio of seizures and epilepsy greater after COVID-19 versus influenza for those who were not hospitalized and those aged younger than 16 years
Bariatric Surgery May Raise Risk for New-Onset Epilepsy
Long-term risk for epilepsy increased for patients receiving bariatric surgery compared with patients with obesity not receiving the surgery
Rates of Psychiatric Symptoms Up During Pregnancy With Epilepsy
Rates of depressive and anxiety symptoms increased during pregnancy and postpartum for women with epilepsy
Transdermal CBD No Better Than Placebo for Drug-Resistant Focal Epilepsy
At week 12, no difference in seizure frequency seen between cannabidiol and placebo as adjunctive therapy in adults
Cost of Brand-Name Antiseizure Meds Increased Since 2010
Brand-name ASMs accounted for 79 percent of costs in 2018, despite representing only 14 percent of pill days
